SCHEMBL27147342

SCHEMBL27147342

C[C@@H](N)c1ncccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
NFKB1 P19838 1/20 0.45
PNMT P11086 1/20 0.45
LMNA P02545 2/20 0.44
ALDH1A1 P00352 2/20 0.44
GLA P06280 1/20 0.44
HRH1 P35367 1/20 0.39
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
DPP4 P27487 1/20 0.37
ADRB2 P07550 1/20 0.37
PDCD1 Q15116 2/20 0.36
CD274 Q9NZQ7 2/20 0.36
TP53 P04637 1/20 0.36
HTT P42858 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22495173 1.00 CYP2D6 (0.45) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL21071356 1.00 CYP2D6 (0.45) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL30824549 1.00 CYP2D6 (0.45) CYP2D6CYP1A2CYP3A4NFKB1PNMT
Hydrochloric Acid SCHEMBL31482194 0.98 LMNA (0.47) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL1690313 0.86 CYP2D6 (0.40) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL17676691 0.83 CYP2D6 (0.38) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL28205012 0.83 CYP2D6 (0.39) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL23006304 0.81 CYP2D6 (0.41) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL28825223 0.81 S1PR3 (0.38) CYP2D6CYP1A2CYP3A4NFKB1PNMT
SCHEMBL1514943 0.81 S1PR3 (0.38) CYP2D6CYP1A2CYP3A4NFKB1PNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067631-A1 PYRAZOLE DERIVATIVES USEFUL AS NAMPT MODULATORS CYTOKINETICS, INC. 2024-02-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240067631-A1 PYRAZOLE DERIVATIVES USEFUL AS NAMPT MODULATORS NAMPT, NNT, NAPRT CYP2D6 2332/4885CYP1A2 1642/4885CYP3A4 1240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.